| Q51294282 | Brachytherapy Using Elastin-Like Polypeptides with (131)I Inhibit Tumor Growth in Rabbits with VX2 Liver Tumor. |
| Q91791312 | Comparison of anesthesia and tumor implantation methods for establishing rabbit VX2 hepatocarcinoma |
| Q27333932 | Comparison of endoscopic submucosal implantation vs. surgical intramuscular implantation of VX2 fragments for establishing a rabbit esophageal tumor model for mimicking human esophageal squamous carcinoma |
| Q33376925 | Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors |
| Q35534035 | Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma |
| Q34210319 | Confirmation of drug delivery after liver chemoembolization: direct tissue doxorubicin measurement by UHPLC-MS-MS. |
| Q39832108 | Development of a VX2 pancreatic cancer model in rabbits: a pilot study |
| Q30408220 | Development, growth, propagation, and angiographic utilization of the rabbit VX2 model of liver cancer: a pictorial primer and "how to" guide. |
| Q37577609 | Distribution of Iron Oxide Core-Titanium Dioxide Shell Nanoparticles in VX2 Tumor Bearing Rabbits Introduced by Two Different Delivery Modalities. |
| Q30571618 | Establishing a rabbit model of malignant esophagostenosis using the endoscopic implantation technique for studies on stent innovation |
| Q36364314 | Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study |
| Q64275004 | Establishment of metastatic liver carcinoma model by implanting AX7 cells into rabbit liver, and its histological findings |
| Q41973745 | Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging |
| Q36481678 | Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors. |
| Q39940937 | Functional magnetic resonance imaging in an animal model of pancreatic cancer. |
| Q33576048 | Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors |
| Q26864803 | Interventional therapies for hepatocellular carcinoma |
| Q39821227 | Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors |
| Q51733150 | Modification of the method to establish a hepatic VX2 carcinoma model in rabbits. |
| Q35326344 | Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model |
| Q34672595 | Rabbit hepatic arterial anatomy variations: implications on experimental design. |
| Q26741499 | Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment. |
| Q39034301 | Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics |
| Q46614619 | Radiofrequency ablation of liver tumors in combination with local OK-432 injection prolongs survival and suppresses distant tumor growth in the rabbit model with intra- and extrahepatic VX2 tumors |
| Q35988578 | Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine |
| Q41785826 | Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study |
| Q39757887 | Role of sonography for implantation and sequential evaluation of a VX2 rabbit liver tumor model |
| Q36295562 | The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model |
| Q55083885 | Ultrasound-guided radiofrequency ablation enhances natural killer-mediated antitumor immunity against liver cancer. |